Unsolved Mystery: V Foundation Grantee, Dr. Majzner, Is Investigating Why CAR T-Cell Therapy Is Failing in DIPG Patients
Many childhood cancers are seeing progress with CAR T-Cell therapy, but Diffuse Intrinsic Pontine Glioma (DIPG), a highly aggressive brain tumor, remains a major challenge.
V Foundation grantee, Dr. Majzner, explores the mystery of why CAR T-Cell therapy, which shows promise in reaching deep brain tumors, seems to fail in some DIPG patients. Let’s delve into the latest research to understand if the tumor is outsmarting the treatment or if the T-Cells themselves need improvement. Dr. Majnzer offers valuable insights into DIPG treatment options and the ongoing research for this cancer.
Mailing List
